Search Results - "SCHORN, T. W"

Refine Results
  1. 1

    Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys by Gibson, R E, Thorpe, H H, Cartwright, M E, Frank, J D, Schorn, T W, Bunting, P B, Siegl, P K

    Published in The American journal of physiology (01-09-1991)
    “…The angiotensin II (ANG II) receptor has recently been shown to exhibit subtypes with respect to antagonist binding. Of particular interest are the potent…”
    Get full text
    Journal Article
  2. 2

    Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin II by Kivlighn, S D, Huckle, W R, Zingaro, G J, Rivero, R A, Lotti, V J, Chang, R S, Schorn, T W, Kevin, N, Johnson, Jr, R G, Greenlee, W J

    Published in The American journal of physiology (01-03-1995)
    “…L-162,313 (5,7-dimethyl-2-ethyl-3-[[4-[2(n- butyloxycarbonylsulfonamido)-5-isobutyl-3-thienyl]phenyl]methyl]- imadazo[4,5-b]pyridine) is a nonpeptide that…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Synthesis and use of 3-amino-4-phenyl-2-piperidones and 4-amino-2-benzazepin-3-ones as conformationally restricted phenylalanine isosteres in renin inhibitors by De Laszlo, S. E, Bush, B. L, Doyle, J. J, Greenlee, W. J, Hangauer, D. G, Halgren, T. A, Lynch, R. J, Schorn, T. W, Siegl, P. K. S

    Published in Journal of medicinal chemistry (01-03-1992)
    “…The design of P2-P3 conformational restrictions in renin inhibitors by the use of a renin computer graphic model led to the synthesis of inhibitors containing…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analog inhibitors containing a novel analog of statine by Boger, Joshua, Payne, Linda S, Perlow, Debra S, Lohr, Nancy S, Poe, Martin, Blaine, Edward H, Ulm, Edgar H, Schorn, Terry W, LaMont, Bruce I

    Published in Journal of medicinal chemistry (01-12-1985)
    “…Analogues of the renin octapeptide substrate were synthesized in which replacement of the scissile dipeptide with (3S,4S)-4-amino-3-hydroxy-6-methylheptanoic…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor by Balani, S K, Goldman, M E, Kauffman, L R, Varga, S L, O'Brien, J A, Smith, S J, Olah, T V, Ramjit, H G, Schorn, T W, Pitzenberger, S M

    Published in Drug metabolism and disposition (01-07-1993)
    “…Rhesus monkeys were dosed orally with 10 mg/kg 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005), a nonnucleoside human immunodeficiency virus type 1…”
    Get more information
    Journal Article
  9. 9

    Highly potent, orally active diester macrocyclic human renin inhibitors by Weber, Ann E, Steiner, Mark G, Krieter, Philip A, Colletti, Adria E, Tata, James R, Halgren, Thomas A, Ball, Richard G, Doyle, John J, Schorn, Terry W

    Published in Journal of medicinal chemistry (01-10-1992)
    “…Replacing one amide bond in macrocyclic renin inhibitors of the general structure 1 and 2 with an ester linkage gave glutamate-derived inhibitors 3 and…”
    Get full text
    Journal Article
  10. 10

    Renin inhibitors containing C-termini derived from mercaptoheterocycles by Ashton, Wallace T, Cantone, Christine L, Meurer, Laura C, Tolman, Richard L, Greenlee, William J, Patchett, Arthur A, Lynch, Robert J, Schorn, Terry W, Strouse, John F, Siegl, Peter K. S

    Published in Journal of medicinal chemistry (01-05-1992)
    “…A series of transition-state analogues having heterocyclythio C-termini has been synthesized and evaluated for inhibition of human renin. Addition of…”
    Get full text
    Journal Article
  11. 11

    Inhibitors of human renin with C-termini derived from amides and esters of .alpha.-mercaptoalkanoic acids by Ashton, Wallace T, Cantone, Christine L, Tolman, Richard L, Greenlee, William J, Lynch, Robert J, Schorn, Terry W, Strouse, John F, Siegl, Peter K. S

    Published in Journal of medicinal chemistry (01-07-1992)
    “…New transition-state analogues bearing C-termini derived from alpha-mercaptoalkanoic acids, esters, and amides were prepared and evaluated as inhibitors of…”
    Get full text
    Journal Article
  12. 12

    The character of the atrial natriuretic response: pressure and volume effects by Blaine, E H, Heinel, L A, Schorn, T W, Marsh, E A, Whinnery, M A

    Published in Journal of hypertension. Supplement (01-06-1986)
    “…Synthetic atrial natriuretic factor (ANF) was compared to the well-characterized diuretics hydrochlorothiazide and furosemide in rats. While ANF was markedly…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition by Schaffer, L W, Schorn, T W, Winquist, R J, Strouse, J F, Payne, L, Chakravarty, P K, de Laszlo, S E, tenBroeke, J, Veber, D F, Greenlee, W J

    Published in Journal of hypertension (01-03-1990)
    “…In order to investigate the hypotensive mechanisms of action of peptide renin inhibitors, blood pressure responses to five renin inhibitors were compared with…”
    Get more information
    Journal Article
  15. 15

    In vivo pharmacology of L-159,913, a new highly potent and selective nonpeptide angiotensin II receptor antagonist by Gabel, R A, Kivlighn, S D, Zingaro, G J, Schorn, T W, Schaffer, L W, Ashton, W T, Chang, L L, Flanagan, K, Greenlee, W J, Siegl, P K

    “…The present study was designed to characterize the in vivo pharmacology of L-159,913 (4-[[2'-(N-benzoylsulfamoyl)biphenyl-4-yl]-5butyl-2,4-dihydr o-2-…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996 by Kivlighn, S D, Zingaro, G J, Gabel, R A, Broten, T P, Schorn, T W, Schaffer, L W, Naylor, E M, Chakravarty, P K, Patchett, A A, Greenlee, W J

    Published in American journal of hypertension (01-01-1995)
    “…MK-996, N-(4'-(5,7-dimethyl-2-ethyl-3H-imidazo[4,5-b]pyridin-3-yl- methyl)1,1'-biphenyl-2-yl)-sulfonylbenzamide, is a potent, orally active, highly selective,…”
    Get more information
    Journal Article
  19. 19

    Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists by Nerenberg, J B, Erb, J M, Thompson, W J, Lee, H Y, Guare, J P, Munson, P M, Bergman, J M, Huff, J R, Broten, T P, Chang, R S, Chen, T B, O'Malley, S, Schorn, T W, Scott, A L

    Published in Bioorganic & medicinal chemistry letters (22-09-1998)
    “…Benign prostatic hyperplasia can be managed pharmacologically with alpha-1 adrenergic receptor antagonists. Agents that demonstrate selectivity for the…”
    Get full text
    Journal Article
  20. 20

    Novel renin inhibitors containing the amino acid statine by Boger, Joshua, Lohr, Nancy S, Ulm, Edgar H, Poe, Martin, Blaine, Edward H, Fanelli, George M, Lin, Tsau-Yen, Payne, Linda S, Schorn, Terry W, LaMont, Bruce I, Vassil, Ted C, Stabilito, Inez I, Veber, Daniel F, Rich, Daniel H, Bopari, Amrit S

    Published in Nature (London) (05-05-1983)
    “…The proteolytic enzyme renin (EC3.4.99.19) cleaves the protein substrate angiotensinogen to yield angiotensin I, the decapeptide substrate transformed by…”
    Get full text
    Journal Article